In particular, PLA nanoparticles readily conjugate targeting ligands, such as antibodies or peptides, to their surface, enabling highly efficient selective drug delivery to cancer cells that overexpress specific receptors, such as HER2 or EGFR. This evidence concerns the gene ERBB2 and cancer.